Live Tumor Board: Squamous Cell Carcinoma of the Head & Neck – Post-CRT Decisions in the Locally Advanced Setting

Overview:

Locally advanced HNSCC remains a high-morbidity disease in which many patients complete concurrent chemoradiation (CRT) yet still face substantial risk of relapse and treatment-related toxicity. There is variability in practice regarding the optimal management of patients after CRT, including strategizing surveillance, interpreting post-treatment imaging, managing toxicities, and considering clinical trial referral. Moreover, multidisciplinary care is essential but challenges remain regarding its practical implementation.

Live Tumor Board: Squamous Cell Carcinoma of the Head & Neck – Post-CRT Decisions in the Locally Advanced Setting, held in conjunction with the 2026 Multidisciplinary Head and Neck Cancers Symposium (MHNCS) Annual Meeting, will feature a case-based discussion led by a multidisciplinary faculty panel. Using realistic post-CRT cases, faculty will discuss how they approach the management of patients in the post-CRT setting, discuss emerging therapies, and provide practical strategies for implementing multidisciplinary care.

Learning Objectives:

Upon completion of this activity, participants will be able to:

• Describe the current role of post-CRT surveillance in patients with LA-HNSCC
• Apply risk-stratified strategies to determine appropriate post-CRT management for patients with LA-NSCC
• Implement coordinated multidisciplinary care plans to mitigate and manage toxicities related to CRT in patients with HNSCC
• Identify potentially eligible patients for ongoing clinical trials evaluating novel post-CRT treatment approaches

Physicians’ Education Resource^®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource^®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Physicians' Education Resource^®, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Physicians' Education Resource^®, LLC has approved this application-based activity for 1.50 ACPE CE hours UAN # 0661-0000-26-002-L01-P. Eligibility for credits requires full attendance, engagement in the live activity, completion and submission of the learner NABP ID # and month and day of birth, activity pre/post-session questions, and the post activity evaluation.

Medical Oncologists (ABIM)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine’s (ABIM). Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.